EBO is proud to announce a strategic partnership with MedBridge North America, marking a key milestone in its global expansion. MedBridge will provide EBO access to a curated network of prospects, across the United States and Canada, who are actively seeking to accelerate their AI adoption.
Under the partnership, MedBridge will serve as an authorised reseller of EBO’s solutions throughout the region. The collaboration will focus on developing scalable go-to-market strategies, securing early deployments across multiple sectors and building a sustainable long-term growth pipeline.
EBO will support this rollout by providing technical enablement, solution demonstrations, and commercial guidance to ensure the successful adoption of its AI-powered solutions within this market.
Serving 19 NHS Trusts across the United Kingdom, EBO has built a strong foundation within a complex public healthcare systems. The company’s technology has since been adopted by organisations across Europe and the Middle East, reflecting its ability to operate effectively across diverse healthcare environments. Beyond healthcare, EBO’s AI solutions have gained significant traction in the Financial Services sector; an area the company will look to further develop through its partnership with MedBridge.
This international exposure has shaped the development of EBO’s core technology, which is designed with global adaptability in mind. The solution operates seamlessly across both public and private healthcare systems (including payer and insurance-driven models) as well as Financial Services. It also accommodates the cultural, operational, and regulatory differences that exist between these markets.
EBO has been designed as a flexible, sector-agnostic platform that adapts to different organisational models, ensuring it remains practical, relevant, and impactful regardless of industry.
